[optimal] Re: Conjunctival FA
- From: Sandor Ferenczy <sandorferenczy@xxxxxxxxx>
- To: optimal@xxxxxxxxxxxxx
- Date: Wed, 29 May 2013 11:38:10 -0400
Katherine,
it is pretty simple - i usually focus as anteriorly as i can, set mag to 35
degrees and focus by moving the camera away from/towards the patient
(similar to a slit lamp)
exposure will need to be set way down, as the white conj will blowout very
quickly. our exposure for a darker iris isnt usually much different than
the retina, but it can be almost impossible to get proper exposure for both
the conj and iris, so be ready to adjust flash level on the fly as you
switch between conj and iris.
-sandor
Sandor Ferenczy, CRA, OCTc
Director of Ophthalmic Photography
Ocular Oncology Service
Wills Eye Institute
840 Walnut Street, 14th Floor
Philadelphia, Pa 19107
www.fighteyecancer.com
On Wed, May 29, 2013 at 11:25 AM, Lee, Katherine K. <leek@xxxxxxxx> wrote:
> We may be asked to do an FA on a patient with recurring sub-conj.
> hemorrhages. Our retina doc says he wants a "conjunctival FA" We have
> a zeiss camera with OIS software, lots of fundus FA experience but really
> no iris FA experience. Any insight you could share would be appreciated
>
> Katherine K Lee COT
> Storm Eye Institute
> 843-792-2764
> fax 792-8865
> pager 17576
>
> If you have received this communication in error, please notify the
> sender immediately.
>
> The documents accompanying this facsimile/electronic transmission contain
> confidential
>
> information intended only for the use of the individual or entity to which
> it is addressed and may contain information that is privileged,
> confidential, and exempt from disclosure. If the reader of this message is
> not the intended recipient, or an employee responsible for delivering the
> message to the intended recipient, you are hereby notified that any
> disclosure, dissemination, distribution, or copying of this communication
> is strictly prohibited.
>
> ------------------------------
> *From:* optimal-bounce@xxxxxxxxxxxxx [optimal-bounce@xxxxxxxxxxxxx] On
> Behalf Of Breit, Peter [BreitP@xxxxxxxx]
> *Sent:* Wednesday, May 29, 2013 9:54 AM
> *To:* optimal@xxxxxxxxxxxxx
> *Subject:* [optimal] FW: IVFA Fluorescein approved versions
>
>
>
> Just for your info in case a patient or doc asked for clarification , I
> believe that was sent by one of you a short while ago.
>
>
>
>
> http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/ucm280534.htm
>
>
>
>
>
> *Thank you*
>
> *Peter*
>
>
>
> Peter L. Breit, CRA.
>
> Director Ophthalmic Services
>
> The Lankenau Hospital & Bryn Mawr Hospital
>
> 484-476-3338
>
> 484-476-8206 fax
>
> 484-437-3262 mobile
>
> page 3707
>
>
>
>
>
>
>
>
>
>
>
>
>
Other related posts:
